CORT – corcept therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Piper Sandler from $128.00 to $131.00. They now have an "overweight" rating on the stock.
Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar? [Yahoo! Finance]
Corcept's Phase III trial of ovarian cancer therapy shows PFS improvement [Yahoo! Finance]
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Canaccord Genuity Group Inc. from $130.00 to $142.00. They now have a "buy" rating on the stock.
Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday? [Yahoo! Finance]
Form 4 CORCEPT THERAPEUTICS For: Mar 31 Filed by: Maduck Sean
Form 4 CORCEPT THERAPEUTICS For: Mar 31 Filed by: Lyon Joseph Douglas
Form 4 CORCEPT THERAPEUTICS For: Apr 01 Filed by: Guyer William
Form 4 CORCEPT THERAPEUTICS For: Mar 31 Filed by: BELANOFF JOSEPH K
Form 144 CORCEPT THERAPEUTICS Filed by: BELANOFF JOSEPH K
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.